HCPCS Q2052: Home IVIG Supplies and Accessories - OpenPayer

Summary & Overview

HCPCS Q2052: Home IVIG Supplies and Accessories

HCPCS Level II code Q2052 designates services, supplies and accessories used in the home for intravenous immune globulin (IVIG) administration. As home infusion gains wider use for chronic immunodeficiency and autoimmune conditions, accurate coding for home IVIG supplies is essential for claims processing, coverage determinations, and care coordination. Nationally, clear use of supply-level HCPCS codes supports appropriate billing for non-medication items that enable safe home administration.

Key payers included in this overview are Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise briefing on the code’s clinical context and typical site of service, an outline of common modifiers reported with supply and home infusion services, and where to locate payer-specific coverage guidance. The publication summarizes benchmarking considerations for facility versus home settings, identifies documentation elements commonly reviewed by payers, and highlights policy areas affecting reimbursement and prior authorization for home IVIG administration.

This summary is intended for billing managers, home infusion providers, and policy analysts seeking a national-level reference on HCPCS Level II code Q2052, including operational implications and where to look for payer-specific rules. Data not available in the input is noted where applicable.

AetnaBlue Cross Blue ShieldCignaUnitedHealthcareMedicareQ2052HCPCS Level IIhome infusionIVIGinfusion supplieshome healthbillingmedical supplies

Billing Code Overview

HCPCS Level II code Q2052 represents services, supplies and accessories used in the home for the administration of intravenous immune globulin (IVIG). This code covers items and ancillary supplies intended to support IVIG delivery outside the acute care setting.

Service type: Home infusion support supplies and accessories

Typical site of service: Patient's home (home infusion setting)

Clinical & Coding Specifications

Clinical Context

A patient with a primary immunodeficiency or an autoimmune neurological disorder receives intravenous immune globulin (IVIG) at home using supplies and accessories billed under Q2052. A typical scenario: a 45-year-old patient with chronic inflammatory demyelinating polyneuropathy (CIDP) has an established plan of care from a neurologist. The patient is clinically stable for home infusion, with vascular access (peripheral IV or implanted port) placed and home infusion nursing arranged by a home infusion provider. Prior to infusion, the home infusion nurse verifies prescriber orders, reviews allergies, obtains baseline vital signs, and inspects the IV access site. The nurse assembles infusion pump, IV tubing, administration sets, infusion stabilizers, and infusion-related ancillary supplies covered by Q2052, prepares the IVIG per manufacturer and compounding standards, programs the pump, and initiates therapy. During infusion the nurse monitors for infusion reactions, documents infusion rate adjustments, and manages symptomatic issues (e.g., hypotension, headache) per protocol. After completion, the nurse flushes the line, disposes of single-use supplies, documents total dose administered and any adverse events, and communicates infusion report to the prescribing clinician. Typical payer interactions include prior authorization from payors such as Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare; durable medical equipment and home infusion vendors coordinate supply delivery and billing. Emergency transport or clinic visits are arranged if severe reactions occur.

Coding Specifications

Modifier	Description	When to Use

HCPCS Q4227: Amniocore, per Square Centimeter (Add-On Supply)

HCPCS-Q0240-CASIRIVIMAB-IMDEVIMAB-600MG-INJECTION

HCPCS Level II Q0240: Injection of casirivimab and imdevimab, 600 mg

HCPCS-Q5154-OMALIZUMAB-OMLYCLO-5MG-INJECTION

HCPCS Level II Q5154: Omalizumab-igec (Omlyclo) Injection, 5 mg

HCPCS-Q4354-PALINGEN-DUAL-LAYER-MEMBRANE-SQ-CM

HCPCS Q4354: Palingen Dual-Layer Membrane, Per Sq Cm

HCPCS-Q4411-AMNIOMATRIX-AMNIOTIC-MATRIX-PER-CM2

HCPCS Level II Q4411: Amniomatrix per Square Centimeter (Add-on)

HCPCS-Q4164-HELICOLL-PER-SQ-CM-ADD-ON

HCPCS Q4164: Helicoll, per Square Centimeter (Add-on)

HCPCS-Q4131-EPIFIX-EPICORD-BIOLOGIC-WOUND-GRAFT-PER-CM2

HCPCS Q4131: Epifix or Epicord, Biologic Wound Graft per cm2

HCPCS-Q5140-ADALIMUMAB-FKJP-BIOSIMILAR-INJECTION-1MG

HCPCS Q5140: Injection, adalimumab-fkjp, biosimilar, 1 mg

HCPCS-Q0511-PHARMACY-SUPPLY-FEE-ORAL-ANTICANCER-IMMUNOSUPPRESSIVE

HCPCS Q0511: Pharmacy Supply Fee for Oral Anticancer/Immunosuppressive Drugs

HCPCS-Q4005-LONG-ARM-PLASTER-CAST-SUPPLIES-ADULT

HCPCS Q4005: Cast Supplies, Long Arm Plaster, Adult (11+)

Showing 1–10 of 629

`00`	No modifier—standard submission	Use when no special circumstances apply and the claim represents routine billing for home IVIG supplies and accessories.
`22`	Increased procedural services	Use when unusually high complexity or resources are required to deliver home IVIG supplies (rare for supply codes; applicable when documentation supports increased work or complexity).
`23`	Unusual anesthesia	Not typically used for `Q2052`; include only if anesthesia is involved and meets payer guidelines.
`52`	Reduced services	Use when less than the full suite of supplies/services described by `Q2052` were provided.
`53`	Discontinued procedure	Use if IVIG administration was started but discontinued prior to completion due to a patient event.
`54`	Surgical care only	Not typically applicable; avoid unless billing rules require separating surgical from supply components.
`55`	Postoperative management only	Not typically applicable to home infusion supplies.
`56`	Preoperative management only	Not typically applicable to home infusion supplies.
`62`	Two surgeons	Not applicable to home infusion supply billing; included only per modifier list for completeness.
`AS`	Clinic or office service by assistant surgeon	Not applicable to supply-only billing for home infusion.
`CO`	Coordination of benefits (payer-specific)	Use when coordination with an external payer is required per billing instructions; verify payer-specific use.
`CQ`	Service furnished under a comprehensive ESRD payment bundle	Use only when IVIG supplies fall under an ESRD bundle per payer policy (rare).
`FX`	Multiple procedure or service reductions adjusted	Use when payment adjustments are required by payer rules for multiple services on same date.
`FY`	Claim adjustment reason (payer-specific)	Use when required by payer for specific financial reporting or adjustments.
`NU`	New equipment	Use if a new durable medical equipment item associated with IVIG administration was provided and payer requires designation.
`QK`	Medical direction of two, three, or four concurrent anesthesia procedures	Not applicable to home IVIG supply billing.
`QX`	CRNA service with medical direction by a physician	Not applicable to supply billing.
`QY`	Medical direction of one CRNA by an anesthesiologist	Not applicable to supply billing.

Taxonomy Code	Specialty	Notes
`163W00000X`	Nurse Practitioner	Home infusion nursing oversight, coordination of supplies and monitoring.
`367500000X`	Clinical Nurse Specialist	Oversight of complex infusion protocols and clinical management.
`3336C0002X`	Home Health Agency	Provides home infusion nursing services and supplies management.
`367A00000X`	Registered Nurse (RN)	Direct administration and monitoring of IVIG in the home setting.
`207RH0000X`	Hematology/Oncology	Prescribers for conditions (e.g., immune deficiencies) who authorize home IVIG therapy.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`D80.9`	Immunodeficiency disorder, unspecified	Common indication for IVIG therapy for replacement of deficient immunoglobulins in the home setting.
`D83.9`	Common variable immunodeficiency, unspecified	A frequent chronic immunodeficiency treated with regular IVIG infusions at home.
`G61.81`	Guillain-Barré syndrome	IVIG is a standard therapy for acute immune-mediated neuropathies; home infusions may be arranged for maintenance or chronic variants.
`G61.0`	Guillain-Barré syndrome (acute)	Acute presentations typically treated inpatient but related diagnoses appear in the care continuum for IVIG.
`G61.85`	Chronic inflammatory demyelinating polyneuropathy (CIDP)	A common neurologic autoimmune condition managed with ongoing IVIG infusions, often delivered at home.
`M32.9`	Systemic lupus erythematosus, unspecified	IVIG may be used as adjunctive therapy in severe autoimmune disease requiring immunomodulation.
`D89.9`	Disorder involving the immune mechanism, unspecified	Catch-all for immune-mediated disorders where IVIG may be indicated.
`M35.9`	Systemic involvement of connective tissue disorder, unspecified	Represents connective tissue diseases that may require IVIG for immunomodulatory therapy.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96365`	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	Often reported when nursing supplies (`Q2052`) are used concurrently with the initial hour of IVIG infusion if the payer requires concurrent CPT infusion reporting.
`96366`	Intravenous infusion, each additional hour	Used for each additional hour of IVIG infusion beyond the initial hour when infusion time-based CPT reporting is required.
`36415`	Collection of venous blood by venipuncture	Frequently performed prior to or during IVIG therapy for baseline labs and monitoring; may be performed by home phlebotomy services.
`36561`	Change of tunneled central venous catheter dressing, without aseptic field	Relevant when maintaining implanted venous access used for repeated home IVIG administrations.
`99070`	Supplies and materials (except spectacles), provided by the physician over and above those usually included with the office visit or service	Some payers accept `99070` for additional supplies; however `Q2052` specifically describes home IVIG supplies and is the HCPCS level II code used by many payers.

OpenPayer